๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Benefits and Risks of Pharmacological Treatments for Essential Tremor

โœ Scribed by Kelly E. Lyons, Dr Rajesh Pahwa, Cynthia L. Comella, Mahmood S. Eisa, Rodger J. Elble, Stanley Fahn, Joseph Jankovic, Jorge L. Juncos, William C. Koller, William G. Ondo, Kapil D. Sethi, Matthew B. Stern, Caroline M. Tanner, Ron Tintner, Ray L. Watts

Book ID
119925423
Publisher
Springer International Publishing AG
Year
2003
Tongue
English
Weight
161 KB
Volume
26
Category
Article
ISSN
0114-5916

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Mechanisms and Emerging Therapies in Tre
Mechanisms and Emerging Therapies in Tremor Disorders Volume 918 || Pharmacological Treatments of Tremor
โœ Grimaldi, Giuliana; Manto, Mario ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Springer New York ๐ŸŒ English โš– 444 KB

Tremor is intimately linked to the numerous interactions of the central and peripheral nervous system components tuning motor control, from the cerebral cortex up to the peripheral effectors. Activities of central generators, reflex loop delays, inertia, stiffness and damping are all factors influen

Levetiracetam for the treatment of essen
Levetiracetam for the treatment of essential tremor
โœ Kelly L. Sullivan; Robert A. Hauser; Theresa A. Zesiewicz ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 35 KB ๐Ÿ‘ 1 views

We read with interest the recent article by Handforth and Martin, 1 "Pilot Efficacy and Tolerability: A Randomized, Placebo-Controlled Trial of Levetiracetam for Essential Tremor." We also performed a pilot study of levetiracetam (LEV, Keppra) for essential tremor (ET) in 6 ET patients to assess its